Identifying Reference Genes for Huntington's Disease Research
Author Information
Author(s): Caroline L Benn, Helen Fox, Gillian P Bates
Primary Institution: King's College London
Hypothesis
A systematic study comparing the suitability of candidate reference genes for use in Huntington's disease mouse models has not been performed.
Conclusion
The study identified a reliable method for accurately determining gene expression levels in specific brain regions, enhancing the potential of gene expression analysis as a biomarker in Huntington's disease pre-clinical trials.
Supporting Evidence
- Commonly used reference genes are dysregulated at later time points in the R6/2 mouse model of Huntington's disease.
- GeNorm software was used to identify the three most stably expressed genes for each brain region.
- Relative quantification methods using the geometric mean of three reference genes enable accurate determination of gene expression levels.
Takeaway
Researchers found that some commonly used genes for measuring other genes' activity don't work well in Huntington's disease models, so they figured out which genes are better to use.
Methodology
The study examined 12 housekeeping genes in R6/2 mice and wild-type controls across different brain regions using qRT-PCR and GeNorm software to identify the most stable reference genes.
Potential Biases
Potential bias in gene selection and analysis methods could affect the reliability of the findings.
Limitations
The study focused on a specific mouse model and may not generalize to other models or human tissues.
Participant Demographics
The study involved 15-week-old R6/2 transgenic mice and matched wild-type littermates.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website